Business
2 blockbuster blue chip ASX shares to buy in January
If you’re planning to add a few blue chip ASX shares to your portfolio in the near future, then I would suggest you consider the two listed below.
As far as two brokers are concerned, they could be among the best on offer on the Australian share market right now. Here’s why they are rated as buys:
CSL is one of the world’s leading biotherapeutics companies and the name behind the high quality CSL Behring and Seqirus businesses. CSL Behring is the global leader in plasma therapies, whereas Seqirus is the second largest influenza vaccines business.
Both of CSL’s businesses have been growing at a solid rate in recent years and have been tipped to continue doing so in the future. This is due to their leading therapies and…
-
Noosa News17 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News22 hours agoFather found stabbed dead upstairs at teenagers’ Brisbane house party
-
Noosa News23 hours agoSA ban on plastic produce stickers on hold as growers struggle with costs
-
General23 hours agoJim Chalmers will have to juggle competing demands to secure tax reform